AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Brain Hemorrhages Article
PDF (359.1 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

Cerebral vasospasm after subarachnoid hemorrhage: Developing treatments

Alvin Y. Chan, Elliot H. Choi, Ichiro Yuki, Shuichi Suzuki, Kiarash Golshani, Jefferson W. Chen, Frank P.K. Hsu( )
Department of Neurological Surgery, University of California, Irvine, CA 92686, USA
Show Author Information

Abstract

Subarachnoid hemorrhage (SAH) can be devastating with high morbidity and mortality. A common sequela is cerebral vasospasm, the narrowing of cerebral blood vessels that can lead to ischemic stroke if not reversed. The current management can vary, though proven treatments include monitoring with transcranial Doppler, avoiding negative fluid balance, a three week course of oral nimodipine, and potential endovascular treatment for direct mechanical reversal of vessel narrowing. However, despite these proven treatment options, vasospasm continues to be poorly understood, anticipated, and ultimately treated. Current research has shown some promise for alternative treatment options, including haptoglobin usage, cerebral spinal fluid (CSF) blood-load reduction, retrieval stent angioplasty, and multimodality monitoring. Here we review the current methods of treatment and research for future treatment modalities being evaluated to combat vasospasm.

Keywords

Subarachnoid hemorrhageComputed tomographyDrug treatmentCerebral vasospasmMultimodality monitoringPrevention therapy

References

1

Lantigua H, Ortega-Gutierrez S, Schmidt JM, et al. Subarachnoid hemorrhage: Who dies, and why?. Crit Care. 2015;19: 309.
Crossref Google Scholar
2

Pandey AS, Gemmete JJ, Wilson TJ, et al. High subarachnoid hemorrhage patient volume associated with lower mortality and better outcomes. Neurosurgery. 2015;77: 462–470. discussion 470.
Crossref Google Scholar
3

Rincon F, Rossenwasser RH, Dumont A. The epidemiology of admissions of nontraumatic subarachnoid hemorrhage in the United States. Neurosurgery. 2013;73: 217–222. discussion 212-213.
Crossref Google Scholar
4

Lawton MT, Vates GE. Subarachnoid hemorrhage. N Engl J Med. 2017;377: 257–266.
Crossref Google Scholar
5

Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389: 655–666.
Crossref Google Scholar
6

Mijiti M, Mijiti P, Axier A, et al. Incidence and predictors of angiographic vasospasm, symptomatic vasospasm and cerebral infarction in Chinese patients with aneurysmal subarachnoid hemorrhage. PLoS ONE. 2016;11 e0168657.
Crossref Google Scholar
7

Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery. 2005;56: 633–654.
Crossref Google Scholar
8

Chyatte D, Sundt TM. Cerebral vasospasm after subarachnoid hemorrhage. Mayo Clin Proc. 1984;59: 498–505.
Crossref Google Scholar
9

Inagawa T. Risk factors for cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a review of the literature. World Neurosurg. 2016;85: 56–76.
Crossref Google Scholar
10

Kolias AG, Sen J, Belli A. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. J Neurosci Res. 2009;87: 1–11.
Crossref Google Scholar
11

Zimmermann M, Seifert V. Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery. 1998;43: 863–875. discussion 875-866.
Crossref Google Scholar
12

Sobey CG, Faraci FM. Subarachnoid haemorrhage: what happens to the cerebral arteries?. Clin Exp Pharmacol Physiol. 1998;25: 867–876.
Crossref Google Scholar
13

Al-Tamimi YZ, Orsi NM, Quinn AC, Homer-Vanniasinkam S, Ross SA. A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. World Neurosurg. 2010;73: 654–667.
Crossref Google Scholar
14

Boulouis G, Labeyrie MA, Raymond J, et al. Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis. Eur Radiol. 2016;27: 3333–3342.
Crossref Google Scholar
15

Ciurea AV, Palade C, Voinescu D, Nica DA. Subarachnoid hemorrhage and cerebral vasospasm - literature review. J Med Life. 2013;6: 120–125.
Google Scholar
16

Hafeez S, Grandhi R. Systematic review of intrathecal nicardipine for the treatment of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2019.
Crossref Google Scholar
17

Jabbarli R, Pierscianek D, Darkwah Oppong M, et al. Laboratory biomarkers of delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review. Neurosurg Rev. 2018.
Crossref Google Scholar
18

Al-Mufti F, Amuluru K, Damodara N, et al. Novel management strategies for medically-refractory vasospasm following aneurysmal subarachnoid hemorrhage. J Neurol Sci. 2018;390: 44–51.
Crossref Google Scholar
19

Rao GS, Muthuchellappan R. Cerebral vasospasm: current understanding. Curr Opin Anaesthesiol. 2016;29: 544–551.
Crossref Google Scholar
20

Findlay JM, Nisar J, Darsaut T. Cerebral vasospasm: a review. Can J Neurol Sci. 2016;43: 15–32.
Crossref Google Scholar
21

Greenberg ED, Gold R, Reichman M, et al. Diagnostic accuracy of ct angiography and ct perfusion for cerebral vasospasm: a meta-analysis. AJNR Am J Neuroradiol. 2010;31: 1853–1860.
Crossref Google Scholar
22

Kumar G, Shahripour RB, Harrigan MR. Vasospasm on transcranial doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2016;124: 1257–1264.
Crossref Google Scholar
23

Lysakowski C, Walder B, Costanza MC, Tramèr MR. Transcranial doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm. Stroke. 2001;32: 2292–2298.
Crossref Google Scholar
24

Mastantuono JM, Combescure C, Elia N, Tramer MR, Lysakowski C. Transcranial doppler in the diagnosis of cerebral vasospasm: an updated meta-analysis. Crit Care Med. 2018;46: 1665–1672.
Crossref Google Scholar
25

Frontera JA, Fernandez A, Schmidt JM, et al. Defining vasospasm after subarachnoid hemorrhage: What is the most clinically relevant definition?. Stroke. 2009;40: 1963–1968.
Crossref Google Scholar
26

Mayberg MR. Cerebral vasospasm. Neurosurg Clin N Am. 1998;9: 615–627.
Crossref Google Scholar
27

Dankbaar JW, Rijsdijk M, van der Schaaf IC, Velthuis BK, Wermer MJ, Rinkel GJ. Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology. 2009;51: 813–819.
Crossref Google Scholar
28

Vergouwen MDI, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies. Stroke. 2010;41: 2391–2395.
Crossref Google Scholar
29

Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly Jr ES, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: The modified fisher scale. Neurosurgery. 2006;59: 21–27. discussion 21-27.
Crossref Google Scholar
30

Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6: 1–9.
Crossref Google Scholar
31

Hijdra A, van Gijn J, Nagelkerke NJ, Vermeulen M, van Crevel H. Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke. 1988;19: 1250–1256.
Crossref Google Scholar
32

van Norden AG, van Dijk GW, van Huizen MD, Algra A, Rinkel GJ. Interobserver agreement and predictive value for outcome of two rating scales for the amount of extravasated blood after aneurysmal subarachnoid haemorrhage. J Neurol. 2006;253: 1217–1220.
Crossref Google Scholar
33

Ibrahim GM, Weidauer S, Macdonald RL. Interobserver variability in the interpretation of computed tomography following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2011;115: 1191–1196.
Crossref Google Scholar
34

Lee KH, Lukovits T, Friedman JA. ‘‘Triple-h” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care. 2006;4: 68–76.
Crossref Google Scholar
35

Charpentier C, Audibert G, Guillemin F, et al. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke. 1999;30: 1402–1408.
Crossref Google Scholar
36

Badjatia N, Topcuoglu MA, Buonanno FS, Smith EE, Nogueira RG, Rordorf GA, et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Critical Care Med. 2005;33: 1603–1609. quiz 1623.
Crossref Google Scholar
37

Ko NU, Rajendran P, Kim H, et al. Endothelial nitric oxide synthase polymorphism (-786t->c) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39: 1103–1108.
Crossref Google Scholar
38

Hop JW, Rinkel GJ, Algra A, van Gijn J. Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke. 1999;30: 2268–2271.
Crossref Google Scholar
39

Qureshi AI, Sung GY, Razumovsky AY, Lane K, Straw RN, Ulatowski JA. Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. Crit Care Med. 2000;28: 984–990.
Crossref Google Scholar
40

Singhal AB, Topcuoglu MA, Dorer DJ, Ogilvy CS, Carter BS, Koroshetz WJ. Ssri and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology. 2005;64: 1008–1013.
Crossref Google Scholar
41

Kistler JP, Crowell RM, Davis KR, et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by ct scan: a prospective study. Neurology. 1983;33: 424–436.
Crossref Google Scholar
42

Aldrich EF, Higashida R, Hmissi A, et al. Thick and diffuse cisternal clot independently predicts vasospasm-related morbidity and poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2020;1–9.
Google Scholar
43

Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm–a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308: 619–624.
Crossref Google Scholar
44

Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298: 636–642.
Crossref Google Scholar
45

Kieninger M, Flessa J, Lindenberg N, et al. Side effects of long-term continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care. 2018;28: 65–76.
Crossref Google Scholar
46

Ott S, Jedlicka S, Wolf S, et al. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage. Biomed Res Int. 2014;2014 970741.
Crossref Google Scholar
47

Venkatraman A, Khawaja AM, Gupta S, et al. Intra-arterial vasodilators for vasospasm following aneurysmal subarachnoid hemorrhage: a meta-analysis. J Neurointerventional Surg. 2018;10: 380–387.
Crossref Google Scholar
48

Sandow N, Diesing D, Sarrafzadeh A, Vajkoczy P, Wolf S. Nimodipine dose reductions in the treatment of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2016;25: 29–39.
Crossref Google Scholar
49

Hänggi D, Etminan N, Aldrich F, et al. Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (newton[nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage]). Stroke. 2017;48: 145–151.
Crossref Google Scholar
50

Haley Jr EC, Kassell NF, Torner JC, Truskowski LL, Germanson TP. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study. J Neurosurg. 1994;80: 788–796.
Crossref Google Scholar
51

Barth M, Capelle HH, Weidauer S, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase iia study. Stroke. 2007;38: 330–336.
Crossref Google Scholar
52

Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature. 1994;372: 231–236.
Crossref Google Scholar
53

Shibuya M, Suzuki Y, Sugita K, et al. Effect of at877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg. 1992;76: 571–577.
Crossref Google Scholar
54

Zhao J, Zhou D, Guo J, et al. Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 2006;46: 421–428.
Crossref Google Scholar
55

Suzuki Y, Shibuya M, Satoh S, Sugimoto Y, Takakura K. A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage. Surg Neurol. 2007;68: 126–131. discussion 131-122.
Crossref Google Scholar
56

Suzuki Y, Shibuya M, Satoh S, Sugiyama H, Seto M, Takakura K. Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: Sub-analysis of the post-marketing surveillance study. Neurol Med Chir (Tokyo). 2008;48: 241–247. discussion 247-248.
Crossref Google Scholar
57

Zhao J, Zhou D, Guo J, et al. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol Med Chir (Tokyo). 2011;51: 679–683.
Crossref Google Scholar
58

Inoue M, Sasaki T, Takazawa H, et al. Symptomatic vasospasm in elderly patients with aneurysmal subarachnoid hemorrhage: comparison with nonelderly patients. Acta Neurochirur Suppl. 2013;115: 281–284.
Crossref Google Scholar
59

Liu GJ, Wang ZJ, Wang YF, et al. Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Eur J Clin Pharmacol. 2012;68: 131–139.
Crossref Google Scholar
60

Marinov MB, Harbaugh KS, Hoopes PJ, Pikus HJ, Harbaugh RE. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg. 1996;85: 117–124.
Crossref Google Scholar
61

Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke. 1991;22: 922–927.
Crossref Google Scholar
62

van den Bergh WM, Zuur JK, Kamerling NA, et al. Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage. J Neurosurg. 2002;97: 416–422.
Crossref Google Scholar
63

Dorhout Mees SM, Algra A, Vandertop WP, et al. Magnesium for aneurysmal subarachnoid haemorrhage (mash-2): a randomised placebo-controlled trial. Lancet (London, England). 2012;380: 44–49.
Crossref Google Scholar
64

Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of hmg-coa reductase. Science (New York, NY). 2001;292: 1160–1164.
Crossref Google Scholar
65

Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The lovastatin study group ⅱ. Jama. 1986;256: 2829-2834.
Crossref Google Scholar
66

A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The lovastatin study group ⅲ. Jama. 1988;260: 359-366.
Crossref Google Scholar
67
Mrc/bhf heart protection study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet (London, England). 2002;360: 7-22.
Crossref
68

Endres M, Laufs U, Huang Z, et al. Stroke protection by 3-hydroxy-3-methylglutaryl (hmg)-coa reductase inhibitors mediated by endothelial nitric oxide synthase. PNAS. 1998;95:8880–8885.
Crossref Google Scholar
69

Yamada M, Huang Z, Dalkara T, et al. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by l-arginine after chronic statin treatment. J Cerebral Blood Flow Metabol. 2000;20:709–717.
Crossref Google Scholar
70

Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase ii randomized placebo-controlled trial. Stroke. 2005;36:1627–1632.
Crossref Google Scholar
71

Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke. 2005;36:2024–2026.
Crossref Google Scholar
72

Shen J, Huang KY, Zhu Y, et al. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2017;127:291–301.
Crossref Google Scholar
73

Akhigbe T, Zolnourian A, Bulters D. Cholesterol-reducing agents for treatment of aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis of randomized controlled trials. World Neurosurg. 2017;101:476–485.
Crossref Google Scholar
74

Suzuki R, Masaoka H, Hirata Y, Marumo F, Isotani E, Hirakawa K. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 1992;77:96–100.
Crossref Google Scholar
75

Griessenauer CJ, Starke RM, Foreman PM, et al. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome. J Neurosurg. 2018;128:1311–1317.
Crossref Google Scholar
76

Mascia L, Fedorko L, Stewart DJ, et al. Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2001;32:1185–1190.
Crossref Google Scholar
77

Kramer A, Fletcher J. Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: A meta-analysis. Stroke. 2009;40:3403–3406.
Crossref Google Scholar
78

Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (conscious-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39:3015–3021.
Crossref Google Scholar
79

Macdonald RL, Higashida RT, Keller E, et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012;43:1463–1469.
Crossref Google Scholar
80

Ignarro LJ, Cirino G, Casini A, Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol. 1999;34:879–886.
Crossref Google Scholar
81

Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther. 2005;105:23–56.
Crossref Google Scholar
82

Allen GS. Cerebral arterial spasm. Part 8: The treatment of delayed cerebral arterial spasm in human beings. Surg Neurol. 1976;6:71–80.
Google Scholar
83

Tanaka Y, Masuzawa T, Saito M, et al. Combined administration of fasudil hydrochloride and nitroglycerin for treatment of cerebral vasospasm. Acta Neurochirur Suppl. 2001;77:205–207.
Crossref Google Scholar
84

Thomas JE, Rosenwasser RH, Armonda RA, Harrop J, Mitchell W, Galaria I. Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke. 1999;30:1409–1416.
Crossref Google Scholar
85

Raabe A, Zimmermann M, Setzer M, Vatter H, Berkefeld J, Seifert V. Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm. Neurosurgery. 2002;50:1006–1013.
Crossref Google Scholar
86

Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg. 2003;98:978–984.
Crossref Google Scholar
87

Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2000;31:383–391.
Crossref Google Scholar
88

Egge A, Waterloo K, Sjøholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery. 2001;49:593-605; discussion 605-596
Crossref Google Scholar
89

Turner JD, Mammis A, Prestigiacomo CJ. Erythropoietin for the treatment of subarachnoid hemorrhage: a review. World Neurosurg. 2010;73:500–507.
Crossref Google Scholar
90

Kumral A, Ozer E, Yilmaz O, et al. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol Neonate. 2003;83:224–228.
Crossref Google Scholar
91

Jerndal M, Forsberg K, Sena ES, et al. A systematic review and meta-analysis of erythropoietin in experimental stroke. J Cereb Blood Flow Metabol. 2010;30:961–968.
Crossref Google Scholar
92

Güresir E, Vasiliadis N, Konczalla J, et al. Erythropoietin prevents delayed hemodynamic dysfunction after subarachnoid hemorrhage in a randomized controlled experimental setting. J Neurol Sci. 2013;332:128–135.
Crossref Google Scholar
93

Lin CL, Shih HC, Dumont AS, et al. The effect of 17beta-estradiol in attenuating experimental subarachnoid hemorrhage-induced cerebral vasospasm. J Neurosurg. 2006;104:298–304.
Crossref Google Scholar
94

Ding D, Starke RM, Dumont AS, et al. Therapeutic implications of estrogen for cerebral vasospasm and delayed cerebral ischemia induced by aneurysmal subarachnoid hemorrhage. Biomed Res Int. 2014;2014 727428.
Crossref Google Scholar
95

Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery. 2001;48:723-728; discussion 728-730.
Crossref Google Scholar
96

Fraticelli AT, Cholley BP, Losser MR, Saint Maurice JP, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:893–898.
Crossref Google Scholar
97

Abulhasan YB, Ortiz Jimenez J, Teitelbaum J, Simoneau G, Angle MR. Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia. J Neurosurg. 2020;1–12.
Google Scholar
98

Lan SH, Lai WT, Zheng SY, et al. Upregulation of connexin 40 mediated by nitric oxide attenuates cerebral vasospasm after subarachnoid hemorrhage via the nitric oxide-cyclic guanosine monophosphate-protein kinase g pathway. World Neurosurg. 2020;136:e476–e486.
Crossref Google Scholar
99

Ehlert A, Starekova J, Manthei G, et al. Nitric oxide-based treatment of poor-grade patients after severe aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2020;32:742–754.
Crossref Google Scholar
100

Senbokuya N, Kinouchi H, Kanemaru K, et al. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial. J Neurosurg. 2013;118:121–130.
Crossref Google Scholar
101

Matsuda N, Naraoka M, Ohkuma H, et al. Effect of cilostazol on cerebral vasospasm and outcome in patients with aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial. Cerebrovas Diseases (Basel, Switzerland). 2016;42:97–105.
Crossref Google Scholar
102

Boulouis G, Labeyrie MA, Raymond J, et al. Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis. Eur Radiol. 2017;27:3333–3342.
Crossref Google Scholar
103

Niu PP, Yang G, Xing YQ, Guo ZN, Yang Y. Effect of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurol Sci. 2014;336:146–151.
Crossref Google Scholar
104

Bowman BH, Kurosky A. Haptoglobin: The evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet. 1982;12(189–261):453–1184.
Crossref Google Scholar
105

Levy AP, Levy JE, Kalet-Litman S, et al. Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 2007;27:134–140.
Crossref Google Scholar
106

Goldenstein H, Levy NS, Levy AP. Haptoglobin genotype and its role in determining heme-iron mediated vascular disease. Pharmacol Res. 2012;66:1–6.
Crossref Google Scholar
107

Chaichana KL, Levy AP, Miller-Lotan R, Shakur S, Tamargo RJ. Haptoglobin 2–2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage. Stroke. 2007;38:3266–3271.
Crossref Google Scholar
108

Borsody M, Burke A, Coplin W, Miller-Lotan R, Levy A. Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage. Neurology. 2006;66:634–640.
Crossref Google Scholar
109

Hugelshofer M, Buzzi RM, Schaer CA, et al. Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm. J Clin Invest. 2019;129:5219–5235.
Crossref Google Scholar
110

Zhang ZD, Yamini B, Komuro T, et al. Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot. Stroke. 2001;32:1868–1874.
Crossref Google Scholar
111

Macdonald RL. Pathophysiology and molecular genetics of vasospasm. Acta Neurochirur Suppl. 2001;77:7–11.
Crossref Google Scholar
112

Klimo Jr P, Kestle JR, MacDonald JD, Schmidt RH. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg. 2004;100:215–224.
Crossref Google Scholar
113

Borkar SA, Singh M, Kale SS, et al. Spinal cerebrospinal fluid drainage for prevention of vasospasm in aneurysmal subarachnoid hemorrhage: a prospective, randomized controlled study. Asian J Neurosurg. 2018;13:238–246.
Crossref Google Scholar
114

Qian C, Yu X, Chen J, et al. Effect of the drainage of cerebrospinal fluid in patients with aneurismal subarachnoid hemorrhage: a meta-analysis. Medicine. 2016;95 e5140.
Crossref Google Scholar
115

Kim JH, Yi HJ, Ko Y, Kim YS, Kim DW, Kim JM. Effectiveness of papaverine cisternal irrigation for cerebral vasospasm after aneurysmal subarachnoid hemorrhage and measurement of biomarkers. Neurol Sci. 2014;35:715–722.
Crossref Google Scholar
116

Sasaki T, Kodama N, Kawakami M, et al. Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a study of urokinase concentration and the fibrinolytic system. Stroke. 2000;31:1256–1262.
Crossref Google Scholar
117
Kodama N, Sasaki T, Kawakami M, Sato M, Asari J. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients. Surg Neurol. 2000;53: 110-117; discussion 117-118.
Crossref
118

Kawamoto S, Tsutsumi K, Yoshikawa G, et al. Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 2004;100:236–243.
Crossref Google Scholar
119

Hänggi D, Eicker S, Beseoglu K, Behr J, Turowski B, Steiger HJ. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase i/ii trial on cerebral vasospasm. Central Eur Neurosurg. 2009;70:61–67.
Crossref Google Scholar
120

Sabouri M, Rahmani P, Rezvani M, et al. The effect of irrigation of intracisternal papaverine on cerebral blood flow in subarachnoid hemorrhage. Adv Biomed Res. 2013;2:45.
Crossref Google Scholar
121

Stiefel MF, Spiotta AM, Udoetuk JD, et al. Intra-arterial papaverine used to treat cerebral vasospasm reduces brain oxygen. Neurocrit Care. 2006;4:113–118.
Crossref Google Scholar
122

Jabbarli R, Pierscianek D, Rolz R, et al. Endovascular treatment of cerebral vasospasm after subarachnoid hemorrhage: more is more. Neurology. 2019;93:e458–e466.
Crossref Google Scholar
123

Zwienenberg-Lee M, Hartman J, Rudisill N, et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with fisher grade iii subarachnoid hemorrhage: results of a phase ii multicenter, randomized, clinical trial. Stroke. 2008;39:1759–1765.
Crossref Google Scholar
124

Bhogal P, Pederzani G, Grytsan A, et al. The unexplained success of stentplasty vasospasm treatment: insights using mechanistic mathematical modeling. Clin Neuroradiol. 2019;29:763–774.
Crossref Google Scholar
125

Bhogal P, Loh Y, Brouwer P, Andersson T, Söderman M. Treatment of cerebral vasospasm with self-expandable retrievable stents: proof of concept. J Neurointervent Surg. 2017;9:52–59.
Crossref Google Scholar
126

Bhogal P, Paraskevopoulos D, Makalanda HL. The use of a stent-retriever to cause mechanical dilatation of a vasospasm secondary to iatrogenic subarachnoid haemorrhage. Intervent Neuroradiol. 2017;23:330–335.
Crossref Google Scholar
127

Kwon HJ, Lim JW, Koh HS, et al. Stent-retriever angioplasty for recurrent post-subarachnoid hemorrhagic vasospasm - a single center experience with long-term follow-up. Clin Neuroradiol. 2019;29:751–761.
Crossref Google Scholar
128

Su YS, Ali MS, Pukenas BA, et al. Novel treatment of cerebral vasospasm using solitaire stent retriever-assisted angioplasty: case series. World Neurosurg. 2020;135:e657–e663.
Crossref Google Scholar
129

Gracias VH, Guillamondegui OD, Stiefel MF, Wilensky EM, Bloom S, Gupta R, et al. Cerebral cortical oxygenation: a pilot study. J Trauma. 2004;56:469-472; discussion 472-464.
Crossref Google Scholar
130

Stiefel MF, Spiotta A, Gracias VH, et al. Reduced mortality rate in patients with severe traumatic brain injury treated with brain tissue oxygen monitoring. J Neurosurg. 2005;103:805–811.
Crossref Google Scholar
131

Le Roux PD, Newell DW, Lam AM, Grady MS, Winn HR. Cerebral arteriovenous oxygen difference: a predictor of cerebral infarction and outcome in patients with severe head injury. J Neurosurg. 1997;87:1–8.
Crossref Google Scholar
132

van Santbrink H, vd Brink WA, Steyerberg EW, Carmona Suazo JA, Avezaat CJ, Maas AI. Brain tissue oxygen response in severe traumatic brain injury. Acta Neurochirur. 2003;145:429-438; discussion 438.
Crossref Google Scholar
133

Gopinath SP, Robertson CS, Contant CF, et al. Jugular venous desaturation and outcome after head injury. J Neurol Neurosurg Psychiatry. 1994;57:717–723.
Crossref Google Scholar
134

Helbok R, Kofler M, Schiefecker AJ, et al. Clinical use of cerebral microdialysis in patients with aneurysmal subarachnoid hemorrhage-state of the art. Front Neurol. 2017;8:565.
Crossref Google Scholar
135

Carteron L, Bouzat P, Oddo M. Cerebral microdialysis monitoring to improve individualized neurointensive care therapy: an update of recent clinical data. Front Neurol. 2017;8:601.
Crossref Google Scholar
136

Chen HI, Stiefel MF, Oddo M, Milby AH, Maloney-Wilensky E, Frangos S, et al. Detection of cerebral compromise with multimodality monitoring in patients with subarachnoid hemorrhage. Neurosurgery. 2011;69:53-63; discussion 63.
Crossref Google Scholar
137

Albanna W, Weiss M, Müller M, et al. Endovascular rescue therapies for refractory vasospasm after subarachnoid hemorrhage: a prospective evaluation study using multimodal, continuous event neuromonitoring. Neurosurgery. 2017;80:942–949.
Crossref Google Scholar
138

Sarrafzadeh AS, Haux D, Lüdemann L, et al. Cerebral ischemia in aneurysmal subarachnoid hemorrhage: a correlative microdialysis-pet study. Stroke. 2004;35:638–643.
Crossref Google Scholar
139

Unterberg AW, Sakowitz OW, Sarrafzadeh AS, Benndorf G, Lanksch WR. Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2001;94:740–749.
Crossref Google Scholar
140

Khatibi K, Szeder V, Blanco MB, et al. Role of bedside multimodality monitoring in the detection of cerebral vasospasm following subarachnoid hemorrhage. Acta Neurochir Suppl. 2020;127:141–144.
Crossref Google Scholar
141

Kett-White R, Hutchinson PJ, al-Rawi PG, Gupta AK, O’Connell MT, Pickard JD, et al. Extracellular lactate/pyruvate and glutamate changes in patients during per-operative episodes of cerebral ischaemia. Acta Neurochir Suppl. 2002;81:363–365.
Crossref Google Scholar
142

Foreman B, Ngwenya LB, Stoddard E, Hinzman JM, Andaluz N, Hartings JA. Safety and reliability of bedside, single burr hole technique for intracranial multimodality monitoring in severe traumatic brain injury. Neurocrit Care. 2018;29:469–480.
Crossref Google Scholar
143

Lopez JP, Diallo A, Cruceanu C, et al. Biomarker discovery: quantification of micrornas and other small non-coding rnas using next generation sequencing. BMC Med Genomics. 2015;8:35.
Crossref Google Scholar
144

Pulcrano-Nicolas AS, Proust C, Clarençon F, et al. Whole-blood mirna sequencing profiling for vasospasm in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2018;49:2220–2223.
Crossref Google Scholar
145

Xu H, Stamova B, Ander BP, et al. Mrna expression profiles from whole blood associated with vasospasm in patients with subarachnoid hemorrhage. Neurocrit Care. 2019.
Crossref Google Scholar
146

Aida Y, Kamide T, Ishii H, et al. Soluble receptor for advanced glycation end products as a biomarker of symptomatic vasospasm in subarachnoid hemorrhage. J Neurosurg. 2019;1–9.
Google Scholar
147

Pulcrano-Nicolas AS, Jacquens A, Proust C, et al. Whole blood levels of s1pr4 mrna associated with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2019;1–5.
Crossref Google Scholar
148

Jayamanoharan S, Mangum JE, Stylli S, Ziogas J, Adamides AA. Association between elevated cerebrospinal fluid d-dimer levels and delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. J Clin Neurosci. 2020;76:177–182.
Crossref Google Scholar
149

Sanchez-Peña P, Pereira AR, Sourour NA, et al. S100b as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med. 2008;36:2267–2273.
Crossref Google Scholar
150

Hijdra A, Brouwers PJ, Vermeulen M, van Gijn J. Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke. 1990;21:1156–1161.
Crossref Google Scholar
151

Carlson AP, Hänggi D, Wong GK, et al. Single-dose intraventricular nimodipine microparticles versus oral nimodipine for aneurysmal subarachnoid hemorrhage. Stroke. 2020;51:1142–1149.
Crossref Google Scholar
152

Origitano TC, Wascher TM, Reichman OH, Anderson DE. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (‘‘triple-h” therapy) after subarachnoid hemorrhage. Neurosurgery. 1990;27:729–739. discussion 739-740.
Crossref Google Scholar
Brain Hemorrhages
Volume 2 Issue 1,
March 2021
Pages 15-23
DOI: 10.1016/j.hest.2020.08.003
Cite this article:
Chan AY, Choi EH, Yuki I, et al. Cerebral vasospasm after subarachnoid hemorrhage: Developing treatments. Brain Hemorrhages, 2021, 2(1): 15-23. https://doi.org/10.1016/j.hest.2020.08.003

56

Views

0

Downloads

11

Crossref

8

Web of Science

7

Scopus

Altmetrics
Received: 11 July 2020
Revised: 20 August 2020
Accepted: 21 August 2020
Published: 01 September 2020
© 2020 International Hemorrhagic Stroke Association.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return